Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

27 May 2026 07:00

RNS Number : 7722F
Chesnara PLC
27 May 2026
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

27th May 2026

CHESNARA plc

("Chesnara", "the Company" or the "Group")

 

NOTIFICATION OF PDMR/PCA DEALING

 

Chesnara plc (CSN.L) announces that Steve Murray, Group CEO and a PDMR of the Company, has acquired 4,884 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares"), pursuant to a dividend reinvestment plan. In addition, the Company announces that Elsie Murray, a Person Closely Associated with Steve Murray, has also acquired 1,395 ordinary shares pursuant to the dividend reinvestment plan as well as purchasing a further 9,474 ordinary shares under the exercising by Steve Murray of options resulting from the vesting of awards made under the 2022 Chesnara Save As You Earn Scheme and which he transferred to his PCA. Following the exercise, Steve Murray now holds a total interest in 493,152 Ordinary Shares (including Ordinary Shares held by a PCA).

 

Chesnara plc further announces that Tom Howard, Group CFO and a PDMR of the Company, has acquired 2,219 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares"), pursuant to a dividend reinvestment plan. Following the acquisition, Mr Howard holds a direct interest in 218,012 Ordinary shares.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Steve Murray

2

Reason for the notification

a)

Position/status

Group Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chesnara plc

b)

LEI

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Chesnara plc Ordinary Shares

ID Code: (GB00B00FPT80)

b)

Nature of the transaction 

Ordinary Shares acquired through a dividend reinvestment plan

c)

Price(s) and volume(s)

Price: 323.34p. Volume: 1,981

Price: 324.90p. Volume: 2,903

 

d)

Aggregated information

Volume: 4,884

 

e)

Date of the transaction

 22nd May 2026

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Elsie Murray

2

Reason for the notification

a)

Position/status

PCA of Steve Murray, Group Chief Executive Officer and PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chesnara plc

b)

LEI

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Chesnara plc Ordinary Shares

ID Code: (GB00B00FPT80)

b)

Nature of the transaction 

a) Ordinary Shares acquired through a dividend reinvestment plan.

b) Exercise of options over 9,474 Ordinary Shares following vesting of the conditional awards under the 2022 Save As You Earn Scheme.

c)

Price(s) and volume(s)

a) Price: 324.90p Volume: 1,395

b) Price: Nil. Volume: 9,474.

d)

Aggregated information

10,869 shares acquired.

e)

Date of the transaction

a) 22nd May 2026

b) 25th May 2026

f)

Place of the transaction

a) London Stock Exchange (XLON)

b) XOFF

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tom Howard

2

Reason for the notification

a)

Position/status

Group Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chesnara plc

b)

LEI

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Chesnara plc Ordinary Shares

ID Code: (GB00B00FPT80)

b)

Nature of the transaction 

Ordinary Shares acquired through a dividend reinvestment plan

c)

Price(s) and volume(s)

Price: 319.00p. Volume: 1,911

Price: 319.00p. Volume: 308

 

d)

Aggregated information

Volume: 2,219

 

e)

Date of the transaction

 20th May 2026

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

The above notification is made in accordance with the requirements of the UK Market Abuse Regulation.

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Misha Bayliss - +44 20 7427 5465

Oscar Burnett - +44 20 7427 5435

Teneo

E - chesnara@teneo.com

 

 

Notes to Editors

Chesnara plc (CSN.L) is a FTSE 250 European life, pensions and investment company with specialist expertise in consolidation. We now administer c1.4m policies across the Group's business units of Countrywide Assured and Chesnara Life (formerly HSBC Life (UK) Ltd) in the UK, Scildon in the Netherlands and Movestic in Sweden. Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing focused, profitable new business in the UK, Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios. Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 21 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUPWAUPQGQQ
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.